Stay updated on Repotrectinib in Rearranged Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.

Latest updates to the Repotrectinib in Rearranged Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the history list.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe history shows a new Revision: v3.4.2 added and the prior government funding notice/banner removed. These changes affect only site-wide notices and do not modify the study data, eligibility, or results.SummaryDifference0.3%

- Check42 days agoChange DetectedAdded a government funding lapse notice with status guidance and links to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1.SummaryDifference0.3%

- Check49 days agoChange DetectedUI improvements to the record history page include a glossary display option, color-coded change indicators, and an updated revision tag (v3.4.0), with minor capitalization adjustments for FEAR Act text.SummaryDifference0.3%

- Check63 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the history.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision: v3.3.3 was added to the history; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

Stay in the know with updates to Repotrectinib in Rearranged Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.